MX9604483A - Derivados de benzamida, composiciones que contienen dicho derivado y uso de las mismas. - Google Patents
Derivados de benzamida, composiciones que contienen dicho derivado y uso de las mismas.Info
- Publication number
- MX9604483A MX9604483A MX9604483A MX9604483A MX9604483A MX 9604483 A MX9604483 A MX 9604483A MX 9604483 A MX9604483 A MX 9604483A MX 9604483 A MX9604483 A MX 9604483A MX 9604483 A MX9604483 A MX 9604483A
- Authority
- MX
- Mexico
- Prior art keywords
- derivative
- compositions containing
- benzamide
- compound
- symbols
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
La presente invencion se refiere a un nuevo compuesto de la formula I, con uno de los símbolos R1, R2, R3, R4 y R5 que representan OH, mientras que los símbolos restantes representan H; a una composicion farmacéutica que contiene el mencionado compuesto, y al uso de dicho compuesto como agente antiparasitario, antibacteriano, antimicotico y antiviral.
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08227033 | 1994-04-13 | ||
US08301407 | 1994-09-08 | ||
US08/301,407 US5578621A (en) | 1994-09-08 | 1994-09-08 | Benzamide derivatives |
US38385595A | 1995-02-06 | 1995-02-06 | |
US383855 | 1995-02-06 | ||
US383,855 | 1995-02-06 | ||
PCT/EP1995/001334 WO1995028393A1 (en) | 1994-04-13 | 1995-04-11 | Benzamide derivative, compositions containing said derivative and use thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
MXPA96004483A MXPA96004483A (es) | 1998-02-01 |
MX9604483A true MX9604483A (es) | 1998-02-28 |
Family
ID=26972350
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX9604483A MX9604483A (es) | 1994-09-08 | 1995-04-11 | Derivados de benzamida, composiciones que contienen dicho derivado y uso de las mismas. |
Country Status (2)
Country | Link |
---|---|
US (2) | US5886013A (es) |
MX (1) | MX9604483A (es) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6653318B1 (en) | 1999-07-21 | 2003-11-25 | Yale University | 5-(E)-Bromovinyl uracil analogues and related pyrimidine nucleosides as anti-viral agents and methods of use |
US7125568B2 (en) | 2001-08-23 | 2006-10-24 | Sung Michael T | Lipophilic drug compositions |
CA2467321A1 (en) * | 2004-05-14 | 2005-11-14 | Paul J. Santerre | Polymeric coupling agents and pharmaceutically-active polymers made therefrom |
UA90864C2 (en) * | 2004-09-09 | 2010-06-10 | Ромарк Лебораториз, Л.К. | Halogenated benzamide derivatives |
US20060194853A1 (en) * | 2004-10-08 | 2006-08-31 | Rossignol Jean F | Alkyl benzamides |
CA2604640A1 (en) * | 2005-04-12 | 2006-10-19 | Romark Laboratories L.C. | Methods for treating diseases through interruption of protein maturation, compounds that inhibit the function of molecular chaperones such as protein disulfide isomerases or interfere with glycosylation, pharmaceutical compositions comprising them, and screening methods for identifying therapeutic agents |
ZA200806310B (en) * | 2006-01-09 | 2009-12-30 | Romark Lab Lc | Viral hepatitis treatment |
PT2178852E (pt) * | 2007-08-03 | 2015-11-12 | Romark Lab Lc | Compostos tiazolida substituídos com alquilsulfonilo |
PL2395840T3 (pl) | 2009-02-13 | 2020-09-07 | Romark Laboratories, L.C. | Preparaty farmaceutyczne nitazoksanidu o kontrolowanym uwalnianiu |
SG10201402281WA (en) * | 2009-05-12 | 2014-07-30 | Romark Lab Lc | Haloalkyl heteroaryl benzamide compounds |
BRPI1014322A2 (pt) | 2009-06-26 | 2015-08-25 | Romark Lab Lc | Método para tratar infecção, e para interromper ou evitar a produção de partículas virais infecciosas, combinação, e, composição farmacêutica. |
ES2767304T3 (es) | 2011-05-16 | 2020-06-17 | Romark Laboratories Lc | Utilización de compuestos de tiazolida para la prevención y el tratamiento de enfermedades víricas, cáncer y enfermedades causadas por infecciones intracelulares |
JP6633092B2 (ja) | 2014-11-11 | 2020-01-22 | ロマーク ラボラトリーズ,リミティド カンパニー | チゾキサニド、その類似体又は塩のプロドラッグを用いる組成物及び治療方法 |
CA3113354A1 (en) | 2016-03-31 | 2017-10-05 | Romark Laboratories, L.C. | Thiazolide compounds for treating viral infections |
EP3777855B1 (en) | 2016-04-11 | 2022-10-19 | Genfit | Methods of treatment for fibrotic diseases |
US11173149B2 (en) | 2017-04-18 | 2021-11-16 | Romark Laboratories L.C. | Inhibition of protein disulfide-isomerase A3 |
US11612567B2 (en) | 2018-02-02 | 2023-03-28 | Ripple Therapeutics Corporation | Ocular inserts comprising a covalently linked steroid dimer |
CA3176134A1 (en) | 2020-05-01 | 2021-11-04 | Ripple Therapeutics Corporation | Heterodimer compositions and methods for the treatment of ocular disorders |
JP2023537237A (ja) | 2020-07-20 | 2023-08-31 | ロマーク ラボラトリーズ,リミティド カンパニー | チゾキサニドおよび2-ヒドロキシ-n-(5-クロロ-1,3-チアゾル-2-イル)ベンズアミド(rm-4848)とエタノールアミン、モルホリン、プロパノールアミン、ピペラジン、およびn-メチルピペラジンの結晶塩 |
US20230330069A1 (en) | 2020-08-24 | 2023-10-19 | Romark Laboratories, L.C. | Use of thiazolides against coronaviruses |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2132431A (en) * | 1934-04-27 | 1938-10-11 | O'brien Brian | Irradiating method and apparatus |
FR1306603A (fr) * | 1958-08-14 | 1962-10-19 | Innothera Lab Sa | Dérivés thiazoliques et leur procédé de préparation |
FR716M (es) * | 1960-08-05 | 1961-08-07 | ||
DE2132431A1 (de) * | 1971-06-30 | 1973-01-11 | Riedel De Haen Ag | 4-phenyl-thiazolderivate enthaltende pharmazeutische praeparate |
GB1437800A (en) * | 1973-08-08 | 1976-06-03 | Phavic Sprl | Derivatives of 2-benzamido-5-nitro-thiazoles |
FR2435905A1 (fr) * | 1978-09-13 | 1980-04-11 | Anvar | Nouveaux agents molluscicides derives du benzamido-2 nitro-5 thiazole |
US4315018A (en) * | 1978-12-07 | 1982-02-09 | Rossignol Jean F | Specific parasiticidal use of 2-benzamido-5-nitro-thiazole derivatives |
US4962117A (en) * | 1987-11-25 | 1990-10-09 | Merck Frosst Canada, Inc. | Heterazole dialkanoic acids |
FR2677356B1 (fr) * | 1991-06-05 | 1995-03-17 | Sanofi Sa | Derives heterocycliques d'acylamino-2 thiazoles-5 substitues, leur preparation et compositions pharmaceutiques en contenant. |
-
1995
- 1995-04-11 MX MX9604483A patent/MX9604483A/es unknown
-
1997
- 1997-05-01 US US08/847,130 patent/US5886013A/en not_active Expired - Lifetime
-
1998
- 1998-10-13 US US09/170,697 patent/US6020353A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
US5886013A (en) | 1999-03-23 |
US6020353A (en) | 2000-02-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX9604483A (es) | Derivados de benzamida, composiciones que contienen dicho derivado y uso de las mismas. | |
BG100884A (en) | Benzamide derivative, compositions containing said derivative and use thereof | |
NL350075I2 (es) | ||
BR9713925A (pt) | Composto, processo para preparação de um composto, e, composição farmacêutica | |
MY116845A (en) | New 19-nor-pregnene derivatives | |
AP9701039A0 (en) | Derivatives of 2- (2-oxo-ethlidene)-imidazolidin-4-one. | |
MX9604020A (es) | Arilalquildiazinonas. | |
CZ142195A3 (en) | Injectable composition containing derivatives of taxan group | |
IL99775A0 (en) | Antimicrobial agents containing substituted 2-cyclohexan-1-yl-amino derivatives,certain such novel compounds and their preparation | |
GEP20022824B (en) | Antipicornaviral Compounds, Pharmaceutical Compositions Containing the Same and Methods for Treatment | |
GB9408185D0 (en) | New benzamide derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same | |
IL114833A0 (en) | Anthracyclinone derivatives their preparation and pharmaceutical compositions containing them | |
IL140070A0 (en) | Benzamide derivatives and pharmaceutical compositions containing the same | |
ATE240331T1 (de) | Azatricyclo(3.3.1.1)decanderivate und diese enthaltende phrmazeutische zubereitungen | |
HU9601587D0 (en) | Antracycline derivatives | |
IL99898A0 (en) | 7-acyl-3-substituted carbamoyloxy cephem compounds,their preparation and antibacterial compositions containing them | |
PL314794A1 (en) | Crystalline polymorphous form of (s,s,s)-n-(1-[2-carbocy-3-(n2-mezilolysilamino)propyl]-1-cyclopentylocabonyl)thyrosine | |
IL150100A0 (en) | Pharmaceutical compositions containing fused cyclic compounds | |
MY133098A (en) | New nitromethyl ketones, process for preparing them and compositions containing them | |
GEP20002095B (en) | Antracycline Disaccharides, Process for Their Preparation and Pharmaceutical Compositions | |
WO2002040005A3 (en) | Blockade of sodium channels by phenol derivatives | |
NZ290236A (en) | Inhibition ofleucotriene biosynthesis and pharmaceutical compositions comprising aryl-urea derivatives | |
TWI256383B (en) | Anthraquinone compound | |
UA41309C2 (uk) | ПОХІДНІ 11-<font face="Symbol">b</font>-БЕНЗАЛЬДОКСИМЕСТРА-4,9-ДІЄНУ, СПОСІБ ЇХ ОТРИМАННЯ ТА ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ |